Symbiotec Pharmalab

Quarterly
Consolidated
ParticularsJun '25Sep '25Mar '26Jun '26Sep '26
Revenue205.81195.68245.41218.49280.04
Expenses160.99162.21210.17200.96215.99
EBITDA60.6150.4562.2545.5391.62
EBIT50.1039.8642.5123.7169.74
Profit Before Tax44.8233.4735.2417.5364.05
Net Profit29.9219.2227.5314.0651.72
Financial Ratios
Operating Profit MarginNA%25.80%25.38%20.88%32.73%
Net Profit MarginNA%9.83%11.22%6.45%18.48%
Earning Per Share (Diluted)5.343.434.762.248.20
Dividends Per Share0.000.000.000.000.00